Baclofen-induced psoriasis

Ann Dermatol Venereol. 2022 Dec;149(4):291-293. doi: 10.1016/j.annder.2022.03.009. Epub 2022 May 25.

Authors

N Sigg¹, J Delaunay², C Potey³, G Drablier⁴

Affiliations

¹ Service de Dermatologie, CHU de Angers, 4, rue Larrey, 49100 Angers, France. Electronic address: nina.sigg@chu-angers.fr.
² Service de Dermatologie, CHU de Angers, 4, rue Larrey, 49100 Angers, France.
³ Centre de Pharmacovigilance, CHU de Lille, 1, place de Verdun, 59045 Lille, France.
⁴ Centre de Pharmacovigilance, CHU de Angers, 4, rue Larrey, 49100 Angers, France.

PMID: 35643883
DOI: 10.1016/j.annder.2022.03.009

No abstract available

Keywords: Baclofen; Induced psoriasis; Pharmacovigilance.

Publication types

Letter

MeSH terms

Adverse Drug Reaction Reporting Systems
Baclofen* / adverse effects
Humans
Pharmacovigilance
Psoriasis* / chemically induced
Psoriasis* / drug therapy

Substances

Baclofen